Shares surged 8% to ₹1,500 as investors digested a 491% jump in net profit.
The jump follows a revenue rise of ₹516.2 crore, up 37.4% YoY from ₹376 crore, and a 32% sequential lift in EBITDA to ₹163.2 crore.
EBITDA margin expanded 3.2 percentage points to 31.6% from 28.4% last year, with operating leverage from higher volumes across all segments.
On a sequential basis, revenue grew 15%, EBITDA jumped 32%, and margins expanded 4.0 points, underscoring the firm’s scaling across markets and new product launches.
The company reiterated FY 2028 guidance of $400m organic revenue and 40% steady‑state EBITDA, while announcing that DDC capacity will triple by FY 2028 with two cartridge lines already in commercial run.
Investors will watch the upcoming FY guidance release on Nov 30 and monitor the completion of line 3 FAT, which could further buoy margins.